Research programme: inflammation and bacterial infection therapeutics - Bloom Burton and Co./Sirona Biochem

Drug Profile

Research programme: inflammation and bacterial infection therapeutics - Bloom Burton and Co./Sirona Biochem

Latest Information Update: 21 Oct 2013

Price : $50

At a glance

  • Originator Sirona Biochem - Bloom Burton & Co (JV)
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Bacterial infections; Inflammation

Most Recent Events

  • 08 Oct 2013 Early research in Bacterial infections in Canada (unspecified route)
  • 08 Oct 2013 Early research in Inflammation in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top